Cargando…
TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors
PURPOSE: Histone citrullination by peptidylarginine deiminases 4 (PAD4) regulates the gene expression of tumor suppressor. In our previously study, YW3-56 (356) was developed as a potent PAD4 inhibitor for cancer therapy with novel function in the autophagy pathway. To enhance the antitumor activity...
Autores principales: | Song, Songlin, Gui, Lin, Feng, Qiqi, Taledaohan, Ayijiang, Li, Yuanming, Wang, Wei, Wang, Yanming, Wang, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490092/ https://www.ncbi.nlm.nih.gov/pubmed/32982225 http://dx.doi.org/10.2147/IJN.S255546 |
Ejemplares similares
-
RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety
por: Lu, Yu, et al.
Publicado: (2021) -
PAD4 and Its Inhibitors in Cancer Progression and Prognosis
por: Zhu, Di, et al.
Publicado: (2022) -
Synergistic Enhancement of Antitumor Efficacy by PEGylated Multi-walled Carbon Nanotubes Modified with Cell-Penetrating Peptide TAT
por: Hu, Shanshan, et al.
Publicado: (2016) -
Effect of TAT-DOX-PEG irradiated gold nanoparticles conjugates on human osteosarcoma cells
por: Lupusoru, Raoul V., et al.
Publicado: (2020) -
TAT and HA2 Facilitate Cellular Uptake of Gold Nanoparticles but Do Not Lead to Cytosolic Localisation
por: Cesbron, Yann, et al.
Publicado: (2015)